How PE-backed healthcare companies can begin decarbonising today
With healthcare responsible for over 4% of global emissions, pressure is mounting – from global pharma, regulators, and payers – for decarbonisation across the value chain.
This webinar is the first part of a series designed to help private equity-backed healthcare companies and pharma manufacturers accelerate their decarbonisation journey. Finance, corporate sustainability and energy advisors from Europe and North American will provide a strategic This session provides a strategic framework for initiating decarbonisation programmes across Scopes 1, 2 and 3.
- Overall context & expectations from investors
- How life cycle assessments (LCA) and supplier prioritisation can guide early actions
- Current state of decarbonisation for the main leaders in the sector plus the lessons learned from a recent project with international client.
The series is designed for pharmaceutical manufacturers as well as healthcare-focused private equity firms and their portfolio companies, with insights applicable to both operational leaders, and sustainability teams.
